Coronary Heart DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Coronary Heart Disease
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
New York-Presbyterian/Columbia University Medical Center
Gregg Stone is a Cardiologist practicing medicine in New York,, New York. Dr. Stone is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Coronary Heart Disease, Mitral Valve Regurgitation, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.
Houston Methodist Debakey Cardiology Associates
Khurram Nasir is a Cardiologist practicing medicine in Houston, Texas. Dr. Nasir is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, High Cholesterol, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.
Guggenheim Pavilion
George Dangas is a Cardiologist practicing medicine in New York, New York. Dr. Dangas is rated as an Elite provider by MediFind in the treatment of Coronary Heart Disease. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Heart Attack, Aortic Valve Stenosis, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).
Summary: The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).
Summary: Chronological aging significantly contributes to structural and functional alterations in the vasculature, making it a major risk factor for atherosclerotic disease and its acute thrombotic events. DNA damage, including telomeric, non-telomeric, and mitochondrial damage, is recognized as a key initiator of vascular aging and atherogenesis. There is abundant evidence indicating the presence of oxid...